Stockreport

How The PAVmed (PAVM) Narrative Is Shifting After The Latest Analyst Reassessment [Yahoo! Finance]

PAVmed Inc.  (PAVM) 
US:NASDAQ Investor Relations: ir.pavm.com
PDF PAVmed's latest analyst update centers on a recalibrated price target, with fair value moving from US$510.00 to US$263.00, a reduction of roughly 48% that materially re [Read more]